Question 1

Is Dabigatran-Etexilate-Mesilate currently in shortage?

Accepted Answer

Yes. As of the latest regulator updates, Dabigatran-Etexilate-Mesilate has 14 active shortage notices across 6 countries (Australia, United States, Italy, Canada, Belgium, Spain). Status is refreshed daily from official regulatory sources.

Question 2

Why is Dabigatran-Etexilate-Mesilate in shortage?

Accepted Answer

Regulators attribute the current Dabigatran-Etexilate-Mesilate shortages to causes not stated by the regulator, manufacturing problems, supply-chain disruption. The exact cause varies by country and product — each notice on this page links to the official source.

Question 3

When will the Dabigatran-Etexilate-Mesilate shortage be resolved?

Accepted Answer

Regulator-estimated resolution dates currently range from 8 May 2026 to 30 Sept 2026, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.

Question 4

Where does this Dabigatran-Etexilate-Mesilate shortage data come from?

Accepted Answer

Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.

Country	Severity	Notices	Since	Est. resolution	Source
Australia	critical	1	17 Aug 2026	30 Sept 2026	TGA
United States	high	2

Dabigatran-Etexilate-Mesilate shortage status

Where Dabigatran-Etexilate-Mesilate is in shortage

Why Dabigatran-Etexilate-Mesilate is in shortage

Recent shortage history

Frequently asked questions

Related medicines

Get alerted when Dabigatran-Etexilate-Mesilate status changes